IDEAYA Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
183 RBC Global Healthcare Conference. My name is Greg Renza, one of the Biotech Equity Research Analyst here at RBC. And we're pleased to be joined now by IDEAYA Biosciences. And joining us from the company is the President and CEO Yujiro Hata as well as the CFO Paul Stone. Gentlemen, thanks for joining us.
Okay, Greg, thank you so much for the kind introduction and for the opportunity to participate at this year's fireside chat. We'll look forward to the discussion.
Fantastic, I am as well. And there's certainly a lot going on with IDEAYA, a lot of interesting clinical and program developments as of late. So Yujiro, maybe we can just have to have you provide for those who are new to the IDEAYA story, just an intro to the company, the platform, and the lead assets (inaudible)
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |